Guerbet SA Ordinary Shares 0ELV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €37.85
- Day Range
- €34.20–37.10
- 52-Week Range
- €15.70–38.95
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €430.57 Mil
- Volume/Avg
- 357 / 1,535
Key Statistics
- Price/Earnings (Normalized)
- 18.07
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- 1.46%
- Dividend Yield (Forward)
- 1.46%
- Total Yield
- 1.46%
Company Profile
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,057
- Website
- http://www.guerbet.com
Comparables
Valuation
|
Metric
|
0ELV
|
CAJ
|
HLS
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.07 | 17.06 | 2.84 |
Price/Book Value | 1.14 | 1.95 | 1.00 |
Price/Sales | 0.54 | 1.14 | 0.52 |
Price/Cash Flow | 5.32 | 7.16 | 3.06 |
Price/Earnings
0ELV
CAJ
HLS
Financial Strength
|
Metric
|
0ELV
|
CAJ
|
HLS
|
|---|---|---|---|
Quick Ratio | 1.06 | 0.56 | 0.44 |
Current Ratio | 2.54 | 0.64 | 0.53 |
Interest Coverage | 3.89 | 2.10 | −13.26 |
Quick Ratio
0ELV
CAJ
HLS
Profitability
|
Metric
|
0ELV
|
CAJ
|
HLS
|
|---|---|---|---|
Return on Assets (Normalized) | 2.26% | 3.21% | 0.10% |
Return on Equity (Normalized) | 5.91% | 7.48% | 0.23% |
Return on Invested Capital (Normalized) | 4.06% | 5.67% | 2.27% |
Return on Assets
0ELV
CAJ
HLS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Wqhlfspq | Jrgcl | $180.4 Bil | |||
| Stryker Corp
SYK
| Zxzystfyr | Lkly | $131.4 Bil | |||
| Boston Scientific Corp
BSX
| Tnfznykmw | Tpdbxw | $112.9 Bil | |||
| Medtronic PLC
MDT
| Bkbwrhhl | Jrbrl | $106.3 Bil | |||
| Edwards Lifesciences Corp
EW
| Dvvpwwdnsm | Dlkstgg | $52.6 Bil | |||
| DexCom Inc
DXCM
| Mbftkdlp | Dxdsp | $45.9 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Rkwnprzt | Fsspzy | $24.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Wgdjvpcb | Xrkjl | $22.1 Bil | |||
| Steris PLC
STE
| Hrywnbm | Ygmswc | $21.6 Bil | |||
| Align Technology Inc
ALGN
| Mstwgmbb | Hpyhz | $19.3 Bil |